Skip to main content

Year: 2023

Interim Financial Report for the Period 1 January – 30 September 2023

Company Announcement No. 9 – 2023 to Nasdaq Copenhagen26 October 2023 Interim financial report for the first nine months of 2023 Consolidated revenue for the third quarter of 2023 was DKK 1,229.3 million, which is DKK 99.3 million, or 7.5%, less than for the third quarter of 2022. Consolidated revenue for the first nine months of 2023 was DKK 3,899.6 million, which is DKK 0.9 million more than for the same period last year. The gross profit margin for the first three quarters decreased by 0.4 percentage point compared with the same period of 2022 driven by one-time effects related to supplier-driven price increases in 2022.  In the third quarter, there was one less selling day relative to the prior year period. The day-to-day sales index saw a sharp decline in September causing third quarter results to be lower than expected. Operating...

Continue reading

BE Semiconductor Industries N.V. Announces Q3-23 Results

Q3-23 Revenue and Net Income of € 123.3 Million and € 35.0 Million, RespectivelyQ3-23 Orders of € 127.3 million, Up 13.1% vs. Q2-23Next € 60 Million Share Repurchase Program Initiated DUIVEN, the Netherlands, Oct. 26, 2023 (GLOBE NEWSWIRE) — BE Semiconductor Industries N.V. (the “Company” or “Besi”) (Euronext Amsterdam: BESI; OTC markets: BESIY), a leading manufacturer of assembly equipment for the semiconductor industry, today announced its results for the third quarter and nine months ended September 30, 2023. Key Highlights Q3-23Revenue Q3-23 of € 123.3 million down 24.1% vs. Q2-23 due to decreased smartphone shipments post H1-23 seasonal capacity build. Partially offset by increased demand for computing and automotive applications. Down 27.0% vs. Q3-22 due primarily to lower demand for computing applications Orders...

Continue reading

Arco Vara AS will hold an investor webinar to introduce the results for the Q3 2023

Arco Vara invites all interested parties to join its investor webinar, scheduled on 26 October 2023 at 10 am (EET). The webinar will be held in Estonian. The webinar will be hosted by the CEO of Arco Vara Miko-Ove Niinemäe, who presents the unaudited financial results of the third quarter of 2023. The webinar takes place at the link: https://arcovara.com/investorile/aruannete-ulekanded/ The webinar will be recorded and remains public on the company’s website.Tiina Malm CFO Arco Vara AS +372 614 4630 tiina.malm@arcovara.com

Continue reading

Medigene Reports Financial Results and Corporate Update for Q3 2023

Focus on executing the strategic plan and delivering shareholder value First MDG2011 pre-clinical data support potential in solid tumor therapy Expansion of patent portfolio and license agreement for technologies in our End-to-End Platform Guidance confirmed; cash runway maintained through Q4 2024Planegg/Martinsried, October 26, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results and provided a corporate update for the third quarter of 2023. The Company’s Quarterly Statement Q3 2023 is available on Medigene’s website: https://medigene.com/investors-media/reports-presentations/ “In the past quarter, we continued to successfully execute our corporate strategy...

Continue reading

Ipsos: Growth acceleration

Growth acceleration Q3 revenue: 588 million euros Organic growth: 4.3% Paris, October 26th, 2023 – Ipsos, one of the world’s leading market research companies, confirms the acceleration of its activity in Q3, in which it recorded 4.3% organic growth (after -2.8% in Q1 and 0.5% in Q2). This illustrates the good momentum of the Group’s activity, despite headwinds on major Tech clients and a weak economic recovery in China. Revenue for the first nine months of the year stands at 1,675.1 million euros, with 0.8% organic growth. Total growth stands at -2.8% due to significant unfavorable exchange rate effects (-3.5%) and slight perimeter effects. PERFORMANCE BY QUARTER  2023 vs. 2022In millions of euros 2023Revenue Total growth Organic growth1st quarter 532.0 -2.9% -2.8% 2nd quarter 555.1 -3.3% 0.5%3rd quarter 588.0 -2.3% 4.3%Revenue 1,675.1 -2.8% 0.8%PERFORMANCE...

Continue reading

Mydecine Provides Q4 2023 Business Update

VANCOUVER, British Columbia, Oct. 26, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD with psychedelic therapeutics, is pleased to address its shareholders and provide a general update on the Company’s progress. The Company has spent the past few months diligently working to simplify its business model, streamline workflow and processes, and reduce burn rate while increasing output and efficiencies in order to ensure the Company’s future success. Through this process, the Company has made a number of strategic decisions that it believes will substantially...

Continue reading

Unaudited consolidated interim report for Q3 and 9 months of 2023

GROUP CEO’S REVIEW Summer is traditionally the low season in the real estate market, but this year it did not apply to Arco Vara, as the third quarter showed. Although interest rates remain high, Arco Vara has been successful in pre-sales and the number of inquiries for our homes has been growing throughout the year. However, in today’s market the million-dollar-question is how to convert a larger number of inquiries into sales. In Kodulahe, we continued building and sales activities as planned, which enables us to start delivering homes in our Kodulahe Rannakalda development already by the time of the publication of the report. We have therefore adjusted the sales revenue and profit projections for 2023 according to the delivery schedule, when according to our assumptions, 65 clients receive a new home. Final sales of 48 units are planned...

Continue reading

AS Tallink Grupp Unaudited Consolidated Interim Report Q3 2023

The Q3 2023 results of AS Tallink Grupp will be introduced at an Investor Webinar held today at 12:00 (EEST). To participate, please join via the following link; we kindly ask participants to provide their questions latest by 11:00 am by email to: investor@tallink.ee. Further details are available in a previously published announcement. In the third quarter (1 July – 30 September) of the 2023 financial year, AS Tallink Grupp and its subsidiaries (the Group) carried 1 775 821 passengers, which is 6.2% less than in the third quarter of 2022. The number of cargo units transported decreased by 26.1% compared to the same period a year ago. The Group’s unaudited consolidated revenue amounted to EUR 240.7 million (EUR 255.6 million in Q3 2022), down by 5.8% year-on-year. Unaudited EBITDA was EUR 82.1 million (EUR 67.7 million in Q3 2022) and...

Continue reading

Hybrid Software Group releases Q3 results

PRESS RELEASE – REGULATED INFORMATION HYBRID SOFTWARE GROUP RELEASES Q3 RESULTS Cambridge (UK) 26 October 2023 (08.00 CEST) – Hybrid Software Group PLC (Euronext: HYSG) provides a trading update for the nine months ended 30 September 2023. CEO Mike Rottenborn comments, “The third quarter of 2023 was marked by overall consistent performance compared to the same period of 2022, with consolidated revenues up 3% and yielding a 19% EBITDA margin. Last year’s third quarter EBITDA was very favourably impacted by the one-time sale of an unused asset (approximately 69,000 IPv4 internet addresses) for a net amount of €3.3 million. On an equivalent basis, EBITDA for the quarter declined to €1.9 million from €2.3 million a year ago. In September the company attended Labelexpo Europe in Brussels, Belgium and successfully launched several significant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.